Our study provides a basis for targeting miR-23a-5p to inhibit RAGE-mediated inflammatory response and alveolar destruction processes in COPD, warranting further exploration as potential therapeutic strategy for COPD. The gene discussed is AGER; the disease is chronic obstructive pulmonary disease.